Grifols (GRFS) Interest & Investment Income (2010 - 2018)

Grifols (GRFS) reported Interest & Investment Income of $8.4 million for Q2 2018, up 83.74% on a YoY basis from $4.6 million in Q2 2017, and up 83.74% quarter-over-quarter from $4.6 million in Q2 2017.

Grifols (GRFS) Interest & Investment Income (2010 - 2018) Analysis & Trends

Grifols has reported Interest & Investment Income for 9 years, with the latest figure at $8.4 million in Q2 2018.

  • For the quarter ending Q2 2018, Interest & Investment Income rose 83.74% year-over-year to $8.4 million; the trailing twelve-month figure through Jun 2018 stood at $8.4 million (up 83.74% YoY), and the FY2025 full-year result was $39.6 million, down 15.83% from the prior year.
  • Interest & Investment Income for Q2 2018 stood at $8.4 million, up from $4.6 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $8.4 million in Q2 2018, with the low at $1.6 million in Q1 2015.
  • Historically, Interest & Investment Income has averaged $4.5 million across 5 years, with a median of $4.4 million in 2016.
  • Annual changes were most pronounced in 2014 — Interest & Investment Income plunged 42.12% — and 2018, when it jumped 83.74%.
  • Grifols' Interest & Investment Income stood at $3.8 million in 2014, then rose by 23.68% to $4.7 million in 2015, then jumped by 59.22% to $7.6 million in 2016, then plunged by 39.38% to $4.6 million in 2017, then soared by 83.74% to $8.4 million in 2018.
  • The last three Interest & Investment Income figures came in at $8.4 million (Q2 2018), $4.6 million (Q2 2017), and $7.6 million (Q3 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 29.66 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 229.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -645.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Grifols 6.05 Bn 5.09 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 8.41 Mn
Jun 30, 2017 4.58 Mn
Sep 30, 2016 7.55 Mn
Jun 30, 2016 4.43 Mn
Mar 31, 2016 2.11 Mn
Sep 30, 2015 4.74 Mn
Jun 30, 2015 3.39 Mn
Mar 31, 2015 1.58 Mn
Dec 31, 2014 3.84 Mn
Dec 31, 2013 6.63 Mn
Sep 30, 2013 5.73 Mn
Jun 30, 2013 4.52 Mn
Mar 31, 2013 2.76 Mn
Dec 31, 2012 2.17 Mn
Sep 30, 2012 1.21 Mn
Jun 30, 2012 1.74 Mn
Mar 31, 2012 3.15 Mn
Dec 31, 2011 7.76 Mn
Sep 30, 2011 3.99 Mn
Jun 30, 2011 2.53 Mn